Several other brokerages have also recently weighed in on CATS. Zacks Investment Research cut Catasys from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. ValuEngine downgraded Catasys from a “buy” rating to a “hold” rating in a research report on Tuesday. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $18.20.
Catasys stock opened at $17.36 on Thursday. The company has a market capitalization of $287.92 million, a PE ratio of -19.51 and a beta of 1.67. The company has a 50 day moving average price of $14.85 and a 200-day moving average price of $16.52. Catasys has a fifty-two week low of $8.71 and a fifty-two week high of $20.83.
Catasys (NASDAQ:CATS) last announced its quarterly earnings data on Wednesday, November 13th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.20). The company had revenue of $8.85 million during the quarter, compared to the consensus estimate of $9.10 million. As a group, research analysts expect that Catasys will post -1.08 earnings per share for the current year.
Large investors have recently bought and sold shares of the company. Eagle Asset Management Inc. purchased a new stake in shares of Catasys in the 2nd quarter worth approximately $269,000. Wells Fargo & Company MN raised its stake in Catasys by 257.7% in the second quarter. Wells Fargo & Company MN now owns 13,773 shares of the company’s stock worth $264,000 after buying an additional 9,923 shares in the last quarter. Allianz Asset Management GmbH raised its stake in Catasys by 332.7% in the second quarter. Allianz Asset Management GmbH now owns 209,542 shares of the company’s stock worth $4,027,000 after buying an additional 161,111 shares in the last quarter. Charles Schwab Investment Management Inc. bought a new position in Catasys in the second quarter worth approximately $372,000. Finally, Bank of New York Mellon Corp purchased a new stake in Catasys during the second quarter worth $302,000. Institutional investors and hedge funds own 19.54% of the company’s stock.
Catasys Company Profile
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Recommended Story: What causes a stock to be most active?
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.